Research Article

Clinical and epidemiological differences in the course of psoriasis in children depending on Vitamin D levels and genotypes of the TaqI polymorphic variant of the VDR gene

Murzina Elvina*

Published: 07 April, 2021 | Volume 5 - Issue 1 | Pages: 006-012

When grouping children with psoriasis depending on TaqI (T/C) genotypes of the VDR gene, the youngest age of disease onset and the longest duration of dermatitis (5.60 ± 0.77 years and 4.90 ± 0.68 years, respectively) showed up in case of the CC genotype. In case of the TT genotype, disease onset coincided with an older age, and the history of present illness was the shortest (10.26 ± 0.64 years and 2.59 ± 0.58 years, respectively). PASI (20.32 ± 3.43) and BSA (40.00 ± 6.11) severity indices were the highest and of statistically significant difference to those in other groups in the presence of the CC genotype. In case of the TC genotype, the index PGA (2.80 ± 0.15) was the lowest and made a statistically significant difference to the values of other groups. A negative correlation between vitamin D levels and the PASI, PGA, BSA was identified in children holding CC and TC genotypes.

Conclusion: The clinical presentation of dermatitis and its epidemiological features in children with psoriasis, namely the age of disease onset, duration of exacerbation, body surface area and the intensity of psoriasis symptoms depend on vitamin D serum levels and genotypes of the TaqI polymorphic variant of the VDR gene.

Read Full Article HTML DOI: 10.29328/journal.adr.1001014 Cite this Article Read Full Article PDF


Psoriasis; Children with psoriasis; TT; TC and CC TaqI (T/C) genotypes of the VDR gene; Vitamin D serum level; PASI; PGA and BSA indices of psoriasis severity


  1. Welsh JE, Wietzke JA, Zinser G, Byrne B, Smith K, et al. Vitamin D-3 Receptor as a Target for Breast Cancer Prevention. J Nutr. 2003; 133: 2425-2433. PubMed: https://pubmed.ncbi.nlm.nih.gov/12840219/ 
  2. Pike JW, Meyers M, Watanuki M, Kim S, Zella LA, et al. Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor. J Steroid Biochem Mol Biol. 2007; 103: 389-395. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868541/
  3. Rukin NJ, Strange RC. What are the frequency, distribution and functional effects of vitamin D receptor polymorphisms as related to cancer risk? Nutr Rev. 2007; 65: 96-101. PubMed: https://pubmed.ncbi.nlm.nih.gov/17867380/
  4. Uitterlinden AG, Fang Y, Van Meurs JBJ, Pols HAP, Van Leeuwen JPTM, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 2338: 143-156. PubMed: https://pubmed.ncbi.nlm.nih.gov/15315818/
  5. Khan MI, Bielecka ZF, Najm MZ, Bartnik E, Czarnecki JS, et al. Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches (Review). Int J Oncol. 2014; 44: 349-363. PubMed: https://pubmed.ncbi.nlm.nih.gov/24297042/
  6. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009; 29: 3511–3536. PubMed: https://pubmed.ncbi.nlm.nih.gov/19667145/
  7. Labuda M, Fujiwara TM, Ross MV, Morgan K, Garcia-Heras J, et al. Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13-14. J Bone Miner Res. 1992; 7: 1447-1453. PubMed: https://pubmed.ncbi.nlm.nih.gov/1336301/
  8. Bid HK, Mishra DK, Mittal RD, Vitamin-D Receptor (VDR) Gene (Fok-I, Taq-I & Apa-I) Polymorphisms in Healthy Individuals from North Indian Population. APJCP. 2005; 6: 147-152. PubMed: https://pubmed.ncbi.nlm.nih.gov/16101324/
  9. Klimova OYU, Berdnikova NG, Kazakov RE. Pleiotropic effects of vitamin D: an essential element of comorbidity therapy. Consilium Medicum. 2017; 19: 114–121.
  10. Richetta AG, Silvestri V, Giancristoforo S, Rizzolo P, D'Epiro S, et al. A-1012G promoter polymorphism of vitamin D receptor gene is associated with psoriasis risk and lower allele-specific expression. DNA Cell Biol. 2014; 33: 102–109. PubMed: https://pubmed.ncbi.nlm.nih.gov/24320988/
  11. Zhou X, Xu LD, Li YZ. The association of polymorphisms of the vitamin D receptor gene with psoriasis in the Han population of northeastern China. J Dermatol Sci. 2014; 73: 63–66. PubMed: https://pubmed.ncbi.nlm.nih.gov/24055231/
  12. Polic MV, Rucevic I, Barisic-Drusko V, Miskulin M, Glavas-Obrovac L, et al. Polymorphisms of vitamin D receptor gene in the population of eastern Croatia with psoriasis vulgaris and diabetes mellitus. Coll Antropol. 2012; 36: 451–457. PubMed: https://pubmed.ncbi.nlm.nih.gov/22856230/
  13. Rucevic I, Stefanic M, Tokic S, Vuksic M, Glavas-Obrovac L, et al. Lack of association of vitamin D receptor gene 3′-haplotypes with psoriasis in Croatian patients. J Dermatol. 2012; 39: 58–62. PubMed: https://pubmed.ncbi.nlm.nih.gov/21951018/
  14. Zuel-Fakkar NM, Kamel MM, Asaad MK, Mahran MZ, Shehab AA. A study of ApaI and TaqI genotypes of the vitamin D receptor in Egyptian patients with psoriasis. Clin Exp Dermatol. 2011; 36: 355–359. PubMed: https://pubmed.ncbi.nlm.nih.gov/21198789/
  15. Ryan C, Renfro L, Collins P, Kirby B, Rogers S. Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis. Br J Dermatol. 2010; 163: 1056–1063. PubMed: https://pubmed.ncbi.nlm.nih.gov/20716226/
  16. Halsall JA, Osborne JE, Pringle JH, Hutchinson PE. Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis. Pharmacogenet Genomics. 2005; 15: 349–355. PubMed: https://pubmed.ncbi.nlm.nih.gov/15864137/
  17. Saeki H, Asano N, Tsunemi Y, Takekoshi T, Kishimoto M, et al. Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris. J Dermatol Sci. 2002; 30: 167–171. PubMed: https://pubmed.ncbi.nlm.nih.gov/12413773/
  18. Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev. 2014; 13: 668-677. PubMed: https://pubmed.ncbi.nlm.nih.gov/24418308/
  19. Fujiyama T, Ito T, Umayahara T, Ikeya S, Tatsuno K, et al. Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion/ J Allergy Clin Immunol. 2016; 138: 517-528. PubMed: https://pubmed.ncbi.nlm.nih.gov/27315769/
  20. Yakovleva OA, Nikolova OM, Doroshkevych IA, Shcherbeniuk NV. Genetic polymorphism of vitamin D receptor determines its metabolism and efficiency. Pain joints spine. 2017; 7: 73-78.
  21. Bhanushali AA, Lajpal N, Kulkarni SS, Chavan SS, Bagadi SS, et al. Das Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels. Indian J Hum Genet. 2009; 15: 108–113. PubMed: https://pubmed.ncbi.nlm.nih.gov/21088715/
  22. Mercy K, Kwasny M, Cordoro KM, Menter A, Tom WL, et al. Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States. Pediatr Dermatol. 2013; 30: 424–428. PubMed: https://pubmed.ncbi.nlm.nih.gov/23360462/
  23. Menter A, Cordoro KM, Davis DMR, Kroshinsky D, Paller AS, et al. Joint American Academy of Dermatology National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020; 82: 161-201. PubMed: https://pubmed.ncbi.nlm.nih.gov/31703821/
  24. Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. https://www.jaad.org/article/S0190-9622(20)32288-X/fulltext
  25. Bożek A, Reich A. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017; 26: 851–856. PubMed: https://pubmed.ncbi.nlm.nih.gov/29068583/
  26. Berezenko VS, Mykhailiuk KZ, Rossokha ZІ, Kyriachenko SP. Correlation of polymorphous variants (ApaI, TagI, BsmI) of the VDR receptor gene with the vitamin D level and liver fibrosis in children with autoimmune hepatitis. Zaporozhye Med J. 2019; 21: 458-465.
  27. Kwon HH, Na SJ, Jo SJ, Youn JI. Epidemiology and clinical features of pediatric psoriasis in tertiary referral psoriasis clinic. J Dermatol. 2012; 39: 260–264. PubMed: https://pubmed.ncbi.nlm.nih.gov/22211370/
  28. Seyhan M, Coskun BK, Saglam H, Ozcan H, Karincaoğlu Y. Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatr Int. 2006; 48: 525–530. PubMed: https://pubmed.ncbi.nlm.nih.gov/17168968/
  29. Shah KN. Diagnosis and treatment of pediatric psoriasis: current and future. Am J Clin Dermatol. 2013; 14: 195–213. PubMed: https://pubmed.ncbi.nlm.nih.gov/23677694/
  30. Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010; 62: 979–987. PubMed: https://pubmed.ncbi.nlm.nih.gov/19962785/
  31. Mattozzi C, Paolino G, Salvi M, Macaluso L, Luci C, et al. Peripheral blood regulatory T cell measurements correlate with serum vitamin D level in patients with psoriasis. Eur Rev Med Pharmacol Sci. 2016; 20: 1675–1679. PubMed: https://pubmed.ncbi.nlm.nih.gov/27212156/
  32. Maleki M, Nahidi Y, Azizahari S, Meibodi NT, Hadianfar A. Serum 25-OH vitamin D level in psoriatic patients and comparison with control subjects. J Cutan Med Surg. 2016; 20: 207–210. PubMed: https://pubmed.ncbi.nlm.nih.gov/26654984/
  33. Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol. 2012; 166: 505–510. PubMed: https://pubmed.ncbi.nlm.nih.gov/22013980/
  34. Chandrashekar L, Kumarit GR, Rajappa M, Revathy G, Munisamy M, et al. 25-Hydroxy vitamin D and ischaemia-modified albumin levels in psoriasis and their association with disease severity. Br J Biomed Sci. 2015; 72: 56–60. PubMed: https://pubmed.ncbi.nlm.nih.gov/26126320/
  35. Orgaz-Molina J, Magro-Checa C, Rosales-Alexander JL, Arrabal-Polo MA, Castellote-Caballero L, et al. Vitamin D insufficiency is associated with higher carotid intima-media thickness in psoriatic patients. Eur J Dermatol. 2014; 24: 53–62. PubMed: https://pubmed.ncbi.nlm.nih.gov/24509438/
  36. Al-Mutairi N, Shaaban D. Effect of narrowband ultraviolet B therapy on serum vitamin D and cathelicidin (LL-37) in patients with chronic plaque psoriasis. J Cutan Med Surg. 2014; 18: 43–48. PubMed: https://pubmed.ncbi.nlm.nih.gov/24377473/
  37. Atwa MA, Balata MG, Hussein AM, Abdelrahman NI, Elminshawy HH, et al. Serum 25-hydroxyvitamin D concentration in patients with psoriasis and rheumatoid arthritis and its association with disease activity and serum tumor necrosis factor-alpha. Saudi Med J. 2013; 34: 806–813. PubMed: https://pubmed.ncbi.nlm.nih.gov/23974451/
  38. Ricceri F, Pescitelli L, Tripo L, Prignano F. Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis. J Am Acad Dermatol. 2013; 68: 511–513. PubMed: https://pubmed.ncbi.nlm.nih.gov/23394917/
  39. Dayangac-Erden D, Karaduman A, Erdem-Yurter H. Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients. Arch Dermatol Res. 2007; 299: 487-491. PubMed: https://pubmed.ncbi.nlm.nih.gov/17763859/


Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?